BRAF and melanoma: In line with this finding, eNAMPT levels were increased in the mice bearing melanoma cells that acquired resistance to BRAF inhibitors as well as in patients with BRAF-mutated metastatic melanoma, and high eNAMPT levels showed a negative correlation with patients’ overall survival [90].